The Department of Veterans Affairs is launching a nationwide clinical trial to determine whether semaglutide, marketed as Ozempic for Type 2 diabetes and Wegovy for chronic weight management, can help treat alcohol use disorder in veterans, a condition VA says has been diagnosed in more than 400,000 veterans nationwide
Cardiovascular protective properties of GLP-1 receptor agonists: more than just diabetic and weight loss drugs
Psychotropic drugrelated weight gain and its treatment
AOD-9604 is most effective when administered in the morning, fasted, approximately 30 minutes before exercise
For the last stubborn 20 pounds (lower back fat biggest repository) looking to stack CJC 1295 & Ipamorelin or AOD9604 with the tirzepatide
For a moderate dose of 250mcg, a 10mg (10,000mcg) vial contains 40 doses